Can I confidently say to patients that a 3-year structured exercise program may save their lives? The CHALLENGE trial (part 2)

Why I would not (yet) implement the CHALLENGE strategy

Aug 7, 2025 • Timothée Olivier

16

2

The online BREAKING-ICE App© out in The Lancet Oncology !

Understanding Censoring in Kaplan-Meier Curves and Exploring Informative Censoring

Aug 2, 2025 • Timothée Olivier

19

5

July 2025

Does a 3-year structured exercise program save lives? Part 1

Can we challenge the CHALLENGE trial results?

Jul 31, 2025 • Timothée Olivier

14

April 2025

"LUNAR: Full Moon or Eclipse? An exploration into tumor treating fields in lung cancer"

This is the title of our new paper out in the Journal of Cancer Policy!

Apr 17, 2025 • Timothée Olivier

11

2

1

How to appraise the control arm in oncology trials, in 10 minutes!

From a recent virtual session I had the pleasure of giving at IOSI, Ticino, Switzerland.

Apr 11, 2025 • Timothée Olivier

21

3

10:03

March 2025

"Surrogate end points in oncology: the speed-uncertainty trade-off from the patients' perspective"

This is my new paper out in Nature Reviews Clinical Oncology

Mar 25, 2025 • Vinay Prasad

32

3

The 19th St Gallen Breast Oncology Conference begins on 12 March 2025 : "Should we combine adjuvant drugs that were tested in isolation in…

Our paper with Vinay Prasad is now published in the Journal of Cancer Policy – and it couldn’t be more timely!

Mar 9, 2025 • Timothée Olivier

10

1

The ‘Duck Test’ for Huey, Dewey and Louie: the legal case on CDK4/6 inhibitors

Me-too drugs (drugs with the same mode of action for the same indication) are generally beneficial to society as they provide variation, choice and…

Mar 6, 2025 • Sahar van Waalwijk and Hans Westgeest

23

1

CDK4/6 Inhibitors and Novel Adjuvant Therapies: Using Statistics to Inform Shared Decision-Making

Here is the talk I gave on March 3rd 2025 at the CRUK Cambridge Institute. Thanks again to Dr. Henno Martin and the team for the invitation and the…

Mar 4, 2025 • Timothée Olivier

16

5

1:01:48

February 2025

Vaccine Safety Research: Too Much Confounding and Spin.

In a systematic review, we found that authors of vaccine safety observational studies conceded residual confounding in about 75% of the studies…

Feb 25, 2025 • Mariana B. Caiado Ferreira

24

1

The CABINET study

100% NIH funded; 100% placebo controlled

Feb 21, 2025 • Vinay Prasad

28

3

1

19:17

Excessive Drug Price Leads to Hefty Fine for Company in the Netherlands

Why was a company fined €17 million for excessive pricing?

Feb 19, 2025 • Sahar van Waalwijk

21

1

1